Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing therapies for debilitating chronic conditions. By optimizing every component of our product candidates, we are improving genetic expression and targeted delivery to realize outsized clinical results.
Building on the successes of our two potential first-in-class therapies for Gaucher disease and adrenomyeloneuropathy (AMN), we’re moving from rare diseases toward more widespread conditions, including forms of Parkinson’s and dementia, and even certain cardiovascular diseases. Expanding our impact, and pushing forward to new frontiers of genetic medicine.
Toward life-changing therapies, and brighter futures.
Toward More™
Company Details
- Employees
- 320
- Founded
- -
- Address
- Gunnels Wood Road, Stevenage,england,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.spurtherapeutics.com
- Keywords
- AAV, Gene Therapy, Life changing, Innovation, Purpose, Biotechnology, Gaucher, Parkinson's disease.
- HQ
- Stevenage, England
Spur Therapeutics Questions
Spur Therapeutics's website is http://www.spurtherapeutics.com
Spur Therapeutics's LinkedIn profile is https://www.linkedin.com/company/spurtherapeutics
Spur Therapeutics has
320 employees.
View email and phone details for 320
employees at Spur Therapeutics.
Spur Therapeutics's industry is
Biotechnology Research
Spur Therapeutics's top competitors are
Resolution Therapeutics,
Ascend Advanced Therapies,
Achilles Therapeutics Plc,
Aviadobio,
Bicycle Therapeutics,
Autolus Therapeutics,
Orchard Therapeutics - U.s.,
Quell Therapeutics,
Swanbio Therapeutics,
Immunocore.
Spur Therapeutics's categories are Biotechnology Research
Spur Therapeutics's founding year is 2015
